| Calcium antagonism and calcium entry blockade. WM Godfraind T, Miller R Pharmacol Rev. 38 (4), 321-416, 1986 | 1656 | 1986 |
| Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle T Godfraind, A Kaba British journal of pharmacology 36 (3), 549, 1969 | 289 | 1969 |
| Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells C Egleme, T Godfraind, RC Miller British journal of pharmacology 81 (1), 16-18, 1984 | 278 | 1984 |
| Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum. T Godfraind The Journal of Physiology 260 (1), 21-35, 1976 | 256 | 1976 |
| Discovery and development of calcium channel blockers T Godfraind Frontiers in pharmacology 8, 259145, 2017 | 224 | 2017 |
| Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries. T Godfraind Journal of Pharmacology and Experimental Therapeutics 224 (2), 443-450, 1983 | 201 | 1983 |
| The role of calcium in the action of drugs on vascular smooth muscle T Godfraind, A Kaba Archives internationales de Pharmacodynamie et de Therapie 196, 35, 1972 | 185 | 1972 |
| Postnatal maturation of excitation-contraction coupling in rat ventricle in relation to the subcellular localization and surface density of 1, 4-dihydropyridine and ryanodine … M Wibo, G Bravo, T Godfraind Circulation research 68 (3), 662-673, 1991 | 176 | 1991 |
| Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries. T Godfraind, RC Miller Circulation research 52 (2 Pt 2), I81-91, 1983 | 139 | 1983 |
| Heterogeneity of ouabain specific binding sites and (Na++ K+)-ATPase inhibition in microsomes from rat heart F Noel, T Godfraind Biochemical pharmacology 33 (1), 47-53, 1984 | 126 | 1984 |
| Binding sites related to ouabain-induced stimulation or inhibition of the sodium pump T Godfraind, J Ghysel-Burton Nature 265 (5590), 165-166, 1977 | 126 | 1977 |
| Mechanisms of action of calcium entry blockers. T Godfraind Federation Proceedings 40 (14), 2866-2871, 1981 | 124 | 1981 |
| Role of endothelium in the contractile response of rat aorta to α-adrenoceptor agonists TO Godfraind, C Egleme, IA Osachie Clinical Science 68 (s10), 65s-71s, 1985 | 123 | 1985 |
| The inhibition by flunarizine of the norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries. T Godfraind, D Dieu Journal of Pharmacology and Experimental Therapeutics 217 (2), 510-515, 1981 | 123 | 1981 |
| Classification of calcium antagonists T Godfraind The American journal of cardiology 59 (3), B11-B23, 1987 | 121 | 1987 |
| Selective alpha 1-and alpha 2-adrenoceptor agonist-induced contractions and 45Ca fluxes in the rat isolated aorta. T Godfraind, RC Miller, JS Lima British journal of pharmacology 77 (4), 597, 1982 | 119 | 1982 |
| EDRF and cyclic GMP control gating of receptor-operated calcium channels in vascular smooth muscle T Godfraind European journal of pharmacology 126 (3), 341-343, 1986 | 113 | 1986 |
| The action of calcium channel blockers on recombinant L-type calcium channel α1-subunits N Morel, V Buryi, O Feron, JP Gomez, MO Christen, T Godfraind British journal of pharmacology 125 (5), 1005, 1998 | 112 | 1998 |
| Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis T Godfraind Philosophical Transactions of the Royal Society B: Biological Sciences 360 …, 2005 | 111 | 2005 |
| Calcium channel blockers in cardiovascular pharmacotherapy T Godfraind Journal of cardiovascular pharmacology and therapeutics 19 (6), 501-515, 2014 | 107 | 2014 |
Olivier FeronUCLouvainVerified email at uclouvain.be
